First Time Loading...

Recordati Industria Chimica e Farmaceutica SpA
MIL:REC

Watchlist Manager
Recordati Industria Chimica e Farmaceutica SpA Logo
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
Watchlist
Price: 50.65 EUR 0.9%
Updated: May 3, 2024

Wall Street
Price Targets

REC Price Targets Summary
Recordati Industria Chimica e Farmaceutica SpA

Wall Street analysts forecast REC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for REC is 53.08 EUR with a low forecast of 43.43 EUR and a high forecast of 65.1 EUR.

Lowest
Price Target
43.43 EUR
14% Downside
Average
Price Target
53.08 EUR
5% Upside
Highest
Price Target
65.1 EUR
29% Upside
Recordati Industria Chimica e Farmaceutica SpA Competitors:
Price Targets
ASRT
Assertio Holdings Inc
203% Upside
4569
Kyorin Holdings Inc
3% Downside
STAR
Strides Pharma Science Ltd
4% Downside
BAI
BenevolentAI SA
298% Upside
001630
Chongkundang Holdings Corp
15% Upside
300401
Zhejiang Garden Bio-chemical High-tech Co Ltd
43% Upside
SOLARA
Solara Active Pharma Sciences Ltd
24% Downside
600436
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
23% Upside

Revenue
Forecast

Revenue Estimate
Recordati Industria Chimica e Farmaceutica SpA

For the last 8 years the compound annual growth rate for Recordati Industria Chimica e Farmaceutica SpA's revenue is 9%. The projected CAGR for the next 3 years is 7%.

9%
Past Growth
7%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Recordati Industria Chimica e Farmaceutica SpA

For the last 8 years the compound annual growth rate for Recordati Industria Chimica e Farmaceutica SpA's operating income is 9%. The projected CAGR for the next 3 years is 11%.

9%
Past Growth
11%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Recordati Industria Chimica e Farmaceutica SpA

For the last 8 years the compound annual growth rate for Recordati Industria Chimica e Farmaceutica SpA's net income is 9%. The projected CAGR for the next 3 years is 15%.

9%
Past Growth
15%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is REC's stock price target?
Price Target
53.08 EUR

According to Wall Street analysts, the average 1-year price target for REC is 53.08 EUR with a low forecast of 43.43 EUR and a high forecast of 65.1 EUR.

What is Recordati Industria Chimica e Farmaceutica SpA's Revenue forecast?
Projected CAGR
7%

For the last 8 years the compound annual growth rate for Recordati Industria Chimica e Farmaceutica SpA's revenue is 9%. The projected CAGR for the next 3 years is 7%.

What is Recordati Industria Chimica e Farmaceutica SpA's Operating Income forecast?
Projected CAGR
11%

For the last 8 years the compound annual growth rate for Recordati Industria Chimica e Farmaceutica SpA's operating income is 9%. The projected CAGR for the next 3 years is 11%.

What is Recordati Industria Chimica e Farmaceutica SpA's Net Income forecast?
Projected CAGR
15%

For the last 8 years the compound annual growth rate for Recordati Industria Chimica e Farmaceutica SpA's net income is 9%. The projected CAGR for the next 3 years is 15%.